Archive
Here you can find the archive of all Press Releases prior to 2018
Filter by date:
Showing 676 press releases before 2019
-
AstraZeneca donates Brixham Environmental Laboratory to Plymouth University
-
European Commission approves Fluenz Tetra for the prevention of seasonal influenza in children
-
AstraZeneca awarded damages in Prilosec® patent litigation
-
Xigduo™ (dapagliflozin and metformin hydrochloride) receives positive CHMP opinion in the European Union for the treatment of type 2 diabetes
-
New Drug Application for naloxegol accepted by United States Food and Drug Administration
-
AstraZeneca appoints architect for new global R&D centre and corporate headquarters in Cambridge, UK
-
AstraZeneca to invest £120 million in new manufacturing facility to produce Zoladex in Macclesfield
-
Marc Dunoyer appointed Chief Financial Officer of AstraZeneca
-
AstraZeneca PLC third quarter and nine months results 2013
-
AstraZeneca advances MedImmune’s benralizumab to Phase III in severe asthma
Latest articles and press releases
All of our latest press releases and articles are available to explore
Contact us
Email the Global Media Relations team at:
Gonzalo Viña
Head of Global Media Relations
+44 (0)1223 344 800
Kim Blomley
Director Global Media Relations (Oncology)
+44 (0)1223 344 800
Matthew Kent
Director Global Media Relations (BioPharmaceuticals)
+44 (0)1223 344 800
Angela Fiorin
Director Global Media Relations (BioPharmaceuticals)
+44 (0)1223 344 800
Fiona Cookson
Director Global Media Relations (Covid-19)
+44 (0)1223 344 800
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
+46 855 253 106
